SCHEMBL4294298

SCHEMBL4294298

O=C(O)c1cc2ccncc2c2cc(Cl)ccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 2/20 0.47
PTGES O14684 1/20 0.47
ALOX5 P09917 1/20 0.47
CYP2C9 P11712 1/20 0.47
HPGD P15428 1/20 0.47
CASP7 P55210 1/20 0.47
HIF1A Q16665 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CSNK2A2 P19784 6/20 0.44
CSNK2B P67870 6/20 0.44
KDM4C Q9H3R0 1/20 0.44
HIPK2 Q9H2X6 1/20 0.43
DHODH Q02127 2/20 0.43
PIM1 P11309 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
CSNK2A1 P68400 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4300956 0.83 CHEK1 (0.53) KDM4EHTTALDH1A1CSNK2A2CSNK2B
SCHEMBL4302560 0.82 RXFP1 (0.64) KDM4EHTTALDH1A1HPGDHSD17B10
SCHEMBL13659557 0.81 KDM4E (0.74) KDM4EHTTALDH1A1CYP2C9HPGD
SCHEMBL1758231 0.75 MEN1 (0.66) ALDH1A1PTGESALOX5CYP2C9HPGD
SCHEMBL4296237 0.75 CCNT1 (0.40) KDM4EHTTCSNK2A2CSNK2BHIPK2
SCHEMBL4295258 0.75 KDM4E (0.41) KDM4EHTTCSNK2A2CSNK2BHIPK2
SCHEMBL4298982 0.73 CHUK (0.49) KDM4EHTTHIPK2
SCHEMBL4300946 0.72 NCOA3 (0.68) KDM4EHTTPTGESHIPK2MEN1
SCHEMBL11325463 0.71 SMN1; SMN2 (0.63) KDM4EALDH1A1PTGESALOX5CYP2C9
SCHEMBL10080459 0.71 MPL (0.48) KDM4EALDH1A1PTGESALOX5CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
US-20090258852-A1 Inhibitors of Checkpoint Kinases MERCK SHARP & DOHME CORP. 2009-10-15 US disclosed
WO-2007008502-A2 INHIBITORS OF CHECKPOINT KINASES MERCK & CO., INC. (US) 2007-01-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090258852-A1 Inhibitors of Checkpoint Kinases CHEK1, CHEK2, CDKN1A KDM4E 366/4885HTT 3947/4885ALDH1A1 2405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.